A theme concerning the establishment and strengthening of systems to comply with laws, standards and guidelines, including the Clinical Trials Act, GCP, GPSP and GVP, in connection with sales information provision activities for pharmaceuticals. This includes the risk that violations or deficiencies could restrict sales activities, damage credibility and increase the burden of responding to them.